Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling KIR-HLA genotype disparities in type 1 diabetes.

A R van der Slik1, B Z Alizadeh, B P C Koeleman

  • 1Department of Immunohaematology & Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.

Tissue Antigens
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased prime edit rates in KCNQ2 and SCN1A via single nicking all-in-one plasmids.

BMC biology·2023
Same author

Persistent C-peptide is associated with reduced hypoglycaemia but not HbA<sub>1c</sub> in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.

International journal of pharmaceutics·2019
Same author

Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings.

Acta psychiatrica Scandinavica·2018
Same author

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

European journal of neurology·2018
Same author

Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.

Genes and immunity·2017

Killer cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) gene combinations influence type 1 diabetes risk. Decreased inhibitory KIR-HLA genotypes are linked to autoimmunity, while activating KIR genotypes also impact overall susceptibility.

Area of Science:

  • Immunogenetics
  • Autoimmunity
  • Type 1 Diabetes Research

Background:

  • Previous studies indicated a link between killer cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class 1 gene distribution and type 1 diabetes susceptibility.
  • Understanding the interplay between KIR and HLA genotypes is crucial for elucidating the mechanisms of autoimmune disease development.

Purpose of the Study:

  • To investigate the combined effects of functional inhibitory and activating KIR genotypes in relation to HLA class 1 in juvenile-onset type 1 diabetes.
  • To compare multiple models assessing the impact of KIR-HLA genotype combinations on type 1 diabetes risk.

Main Methods:

  • Analysis of an extended cohort of patients with juvenile-onset type 1 diabetes and non-diabetic control subjects.
  • Genotyping for KIR and HLA class 1 genes.

Related Experiment Videos

  • Statistical modeling, including logistic regression, to evaluate genotype effects.

    • Main Results:

    • A decrease in inhibitory KIR-HLA genotype combinations was primarily associated with type 1 diabetes autoimmunity.
    • The influence of activating KIR genotypes appeared secondary but was significant in composite models.
    • Logistic regression revealed that activating KIR genotypes modulate the overall hierarchy of protection and susceptibility.

    Conclusions:

    • Autoimmunity in type 1 diabetes is significantly associated with specific KIR-HLA genotype combinations, particularly a reduction in inhibitory interactions.
    • While inhibitory KIR-HLA genotypes play a primary role, activating KIR genotypes also contribute to the complex genetic landscape of type 1 diabetes susceptibility.
    • These findings refine our understanding of the immunogenetic underpinnings of type 1 diabetes and may inform future risk assessment strategies.